Cost of exome analysis in patients with intellectual disability: a micro-costing study in a French setting.
Fiche publication
Date publication
avril 2023
Journal
BMC health services research
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BINQUET Christine, Pr LEJEUNE Catherine, Pr FAIVRE Laurence, Mr DUFFOURD Yannis, Pr THAUVIN-ROBINET Christel
Tous les auteurs :
Soilly AL, Robert-Viard C, Besse C, Bruel AL, Gerard B, Boland A, Piton A, Duffourd Y, Muller J, Poë C, Jouan T, El Doueiri S, Faivre L, Bacq-Daian D, Isidor B, Genevieve D, Odent S, Philip N, Doco-Fenzy M, Lacombe D, Asensio ML, Deleuze JF, Binquet C, , Thauvin-Robinet C, Lejeune C
Lien Pubmed
Résumé
With the development of next generation sequencing technologies in France, exome sequencing (ES) has recently emerged as an opportunity to improve the diagnosis rate of patients presenting an intellectual disability (ID). To help French policy makers determine an adequate tariff for ES, we aimed to assess the unit cost per ES diagnostic test for ID from the preparation of the pre-analytical step until the report writing step and to identify its main cost drivers.
Mots clés
Cost analysis, Exome sequencing, Intellectual disability, Micro-costing
Référence
BMC Health Serv Res. 2023 04 21;23(1):386